Market Overview

UPDATE: Deutsche Bank Upgrades Tenet Healthcare to Buy on Compelling Outlook

Share:
Related THC
Companies That Have The Most To Lose If Obamacare Is Repealed
Watch These 10 Huge Call Purchases In Thursday Trade
Trump vows health 'insurance for everybody' (Seeking Alpha)

Deutsche Bank raised its rating on Tenet Healthcare (NYSE: THC) from Hold to Buy and increased its price target from $31 to $38.

Deutsche Bank noted, "Our upgrade is underpinned by: (1) clear signs of improving business mix and margins due especially to gains in outpatient, (2) tangible momentum in Conifer, and (3) a more sustainable FCF profile going forward. We also continue to highlight the upside risks due to PPACA, and note our 2014 EPS of $3.85 is 17% above consensus. Due to a more favorable outlook, we believe THC should be positioned to garner an in-line (~6x) fwd EV/EBITDA multiple."

Tenet Healthcare closed at $30.63 on Thursday.

Latest Ratings for THC

DateFirmActionFromTo
Jan 2017PiperJaffrayInitiates Coverage OnNeutral
Nov 2016MizuhoDowngradesNeutralUnderperform
Nov 2016Raymond JamesDowngradesOutperformMarket Perform

View More Analyst Ratings for THC
View the Latest Analyst Ratings

Posted-In: Deutsche BankAnalyst Color Upgrades Pre-Market Outlook Analyst Ratings

 

Related Articles (THC)

View Comments and Join the Discussion!